# IBA and Proton International sign contract for ProteusONE proton therapy system in Arkansas

IBA signed a contract with Proton International Arkansas LLC to install a ProteusONE proton therapy solution at the UAMS Winthrop P. Rockefeller Cancer Institute in Little Rock, Arkansas. The system is expected to start treating patients by 2023, with a typical end-user price range of USD 40-50 million including a 10-year maintenance contract.

- Type: Contract
- Announced: 2021-12-23
- Where: Little Rock, Arkansas, United States
- Value: $45.0M
- Status: announced
- Products: proton therapy system
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [IBA S.A.](https://endata.com/companies/44009.md) (supplier)
- [Proton International Arkansas LLC](https://endata.com/companies/59898.md) (customer)
- [University of Arkansas for Medical Sciences](https://endata.com/companies/59899.md) (partner)
- [Baptist Health](https://endata.com/companies/59900.md) (partner)
- [Arkansas Children's](https://endata.com/companies/59901.md) (partner)

## Sources

- [globenewswire.com](https://www.globenewswire.com/news-release/2021/12/23/2357152/0/en/IBA-and-Proton-International-sign-contract-for-Proteus-ONE-Proton-Therapy-solution-in-Arkansas-US.html), 2021-12-23: "The contract includes a long-term operation and maintenance agreement to be provided by IBA, with Proton International LLC expecting to start treating patients by 2023."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.